BCG Clinical Trials in South Africa
south-africa, clinical, trials, covid-19, bcg
Coronavirus trial has begun in South Africa, using a Tuberculosis vaccine called Bacillus Calmette-Guerin or BCG. The trails have started in Cape Town at the Tygerberg hospital, where 250 health care workers were administered the BCG booster shots, while 250 others received a placebo. This is to understand whether the formula can protect against the virus.
As of May 5th, 2020, the country has had 7572 confirmed COVID-19 cases, one of the highest on the continent.
According to TASK founder and expert in internal medicine and pulmonology, Professor Andreas Diacon, the shots have been seen to enable the human immune system to cope better against respiratory infections, and his team will investigate its effects of the COVID-19. Diacon and the TASK organization plans on ramping up trials to about 3,000 health care workers in Cape Town.
Similar trails of BCG are being conducted in Australia, France, and the Netherlands.